By Kewal K. Jain
For physicians, surgeons, and scientists engaged on cardiovascular issues, Applications of Biotechnology in Cardiovascular Therapeutics serves as a useful reference via accumulating the fundamental writings of Dr. Kewal okay. Jain at the issues of biotechnology as they relate to heart problems. This thorough quantity comprises such topics as biotechnology and healing supply to the cardiovascular method, cell-selective designated drug supply, mobile and gene treatments, together with antisense and RNA interference, state-of-the-art gene remedy ways, in addition to custom-made cardiology as a manner of integrating new applied sciences into the choice of the very best remedy for a person sufferer. chosen references from contemporary literature are amassed for every bankruptcy, and the textual content is supplemented through quite a few necessary tables and figures.
Comprehensive and updated, Applications of Biotechnology in Cardiovascular Therapeutics might be greatly valuable for these operating in existence sciences and the pharmaceutical sciences, and the inclusion of a few fundamentals of cardiovascular ailments will vastly gain nonmedical readers as well.
Read or Download Applications of Biotechnology in Cardiovascular Therapeutics PDF
Best cardiovascular books
Now in its completely up-to-date Fourth version, the high blood pressure Primer is a complete, readable resource of state of the art clinical and medical info on high blood pressure. The e-book includes 171 brief chapters via exceptional specialists that hide each element of high blood pressure and its pathogenesis, epidemiology, effect, and administration.
After the winning book of scientific English, Radiological English and first Care English via Springer, I thought of it a most sensible precedence to maintain on writing scientific English books via specialties, that could turn into necessary instruments for overall healthiness care execs and clinical scholars world wide.
The 1st booklet of its style, this reference describes present diagnostic and therapy thoughts for acute and persistent middle failure within the fetus, neonate, baby, and younger adult-encompassing each element of pediatric center failure together with ancient views, the most recent applied sciences in mechanical circulatory aid, and up to date info at the psychosocial features of center failure in young ones.
Counseled by means of the yank Society for Preventive Cardiology, this hugely functional source makes a speciality of the applying of present guidance and perform criteria within the medical administration of cardiovascular hazard elements. The guide provides concise descriptions of every significant cardiovascular probability issue, and useful, to-the-point discussions of present top practices in scientific administration.
- Atrial Fibrillation - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- An Atlas of Investigation and Therapy: Interventional Cardiology
- Bedside Cardiology
- Cardiovascular catheterization and intervention : a textbook of coronary, peripheral, and structural heart disease
- Pediatric Cardiology: Requisites
Extra resources for Applications of Biotechnology in Cardiovascular Therapeutics
These include cardiac surgery, viral diseases, cardiotoxic chemotherapeutics, atherosclerosis of smaller coronary artery branches, environmental toxins such as carbon monoxide, hypoxia, and aging. 2. Those relevant to biotechnology are described in this book. Details of other measures for cardioprotection are beyond the scope of this book. The first strategy in cadioprotection is to remove the causes of ischemic heart disease; the second is to attenuate ongoing ischemic and reperfusion injury; the third is to prevent the progression of cardiac remodeling and chronic heart failure following ischemic injury.
Antioxidant properties of carvedilol can be used to minimize oxidative stress, a powerful inducer of mitochondrial permeability transition. Carvedilol has a positive impact of on the prognosis of patients with coronary heart disease (Carreira et al. 2006). Nebivolol is a selective b1 receptor blocker with nitric oxide-potentiating vasodilatory effect used for the treatment of hypertension as well as left ventricular 22 1 Cardiovascular Therapeutics failure. It avoids many of the side effects of other beta blockers that are caused by their blockade of b2 receptors.
2. Those relevant to biotechnology are described in this book. Details of other measures for cardioprotection are beyond the scope of this book. The first strategy in cadioprotection is to remove the causes of ischemic heart disease; the second is to attenuate ongoing ischemic and reperfusion injury; the third is to prevent the progression of cardiac remodeling and chronic heart failure following ischemic injury. For prevention of acute myocardial infarction, it is widely accepted to treat high-risk patients with aspirin and/or statins.
Applications of Biotechnology in Cardiovascular Therapeutics by Kewal K. Jain